Showing 21-30 of 34 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Pancreatic function; unanticipated insights into progression rate to type 1 diabetes | University of Bristol | Kathleen Gillespie | Cures | 01-September-2024 to 31-August-2027 | $545,259.92 |
| The L selectin pathway in type 1 diabetes | University of Bristol | Kathleen Gillespie | Cures | 01-September-2024 to 31-August-2027 | $827,321.85 |
| Profiling The Kinome In Type 1 Diabetes; Identifying Novel Targets For Biomarker Development and Disease-modifying Therapies | University of Bristol | Anna Long | Cures | 01-April-2025 to 30-September-2026 | $197,076.23 |
| Home-based measures of beta-cell function and CGM metrics to predict progression of pre-symptomatic individuals | University of Cambridge | M. Loredana Marcovecchio | Cures | 01-October-2024 to 30-September-2027 | $855,740.85 |
| Biological Signature of Diabetes Mellitus | University of Cambridge | Kourosh Saeb-Parsy | Cures | 01-August-2023 to 31-July-2027 | $514,959.00 |
| Sotagliflozin in Patients with Heart Failure Symptoms and Type 1 Diabetes (SOPHIST) | University of Dundee | Ify Mordi | Improving Lives | 01-September-2023 to 31-August-2027 | $1,783,962.00 |
| Are we missing something – do the small things matter? | University of Exeter | Sarah Richardson | Cures | 01-May-2025 to 30-April-2028 | $994,000.00 |
| Development of a T1DGRS3 for improved multi-ancestry prediction of type 1 diabetes | University of Exeter | Richard Oram | Cures | 01-June-2026 to 31-May-2029 | $899,463.00 |
| Unlocking the translational potential of extreme forms of autoimmune diabetes by uncovering heterogeneous mechanisms of beta-cell autoimmunity | University of Exeter | Matthew Johnson | Cures | 01-April-2024 to 31-March-2029 | $335,110.00 |
| Novel biomarkers for identification of adult-onset Type 1 diabetes | University of Exeter | Angus Jones | Cures | 01-January-2026 to 31-December-2027 | $898,312.00 |